<unk>  is a tetracyclics and unicyclics that is FDA approved for the {{{indicationType}}} of major depressive disorder (MDD) depression, associated with seasonal affective disorder; prophylaxis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include suicidal thoughts and behaviors in adolescents and young adults, neuropsychiatric symptoms and suicide risk in smoking cessation treatment, seizure, hypertension, activation of mania or hypomania, psychosis and other neuropsychiatric reactions, hypersensitivity reactions.
Bupropion
Atomoxetine
Entropion
Citalopram
Duloxetine
Dapoxetine
Fluoxetine
Escitalopram